The company's UK arm, Cipla (EU) has completed the acquisition of two US-based companies, InvaGen Pharmaceuticals Inc., and Exelan Pharmaceuticals Inc.
"Cipla today announced that its UK arm, Cipla EU has entered into definitive agreements to acquire two US-based companies, InvaGen Pharmaceuticals Inc, and Exelan Pharmaceuticals Inc," said the Mumbai-based pharma company in its filing.